相似文献
1
Cancer to bone: a fatal attraction.
Nat Rev Cancer. 2011 Jun;11(6):411-25. doi: 10.1038/nrc3055. Epub 2011 May 19.
2
Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
Bone. 2011 Jan;48(1):44-53. doi: 10.1016/j.bone.2010.06.007. Epub 2010 Jun 16.
3
Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
Cancer Treat Rev. 2000 Feb;26(1):11-27. doi: 10.1053/ctrv.1999.0143.
4
TGF-β in cancer and bone: implications for treatment of bone metastases.
Bone. 2011 Jan;48(1):23-9. doi: 10.1016/j.bone.2010.08.004. Epub 2010 Aug 10.
5
The endocrine influence on the bone microenvironment in early breast cancer.
Endocr Relat Cancer. 2016 Dec;23(12):R567-R576. doi: 10.1530/ERC-16-0238. Epub 2016 Sep 29.
6
Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment.
Biomolecules. 2020 Feb 19;10(2):337. doi: 10.3390/biom10020337.
7
Basic and clinical associations between bone and cancer.
Immunol Med. 2020 Sep;43(3):103-106. doi: 10.1080/25785826.2020.1754084. Epub 2020 Apr 17.
8
Examining the metastatic niche: targeting the microenvironment.
Semin Oncol. 2010 Oct;37 Suppl 2:S2-14. doi: 10.1053/j.seminoncol.2010.10.007.
9
The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
Curr Pharm Des. 2010;16(11):1284-90. doi: 10.2174/138161210791034012.
10
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Prostate. 2006 Jan 1;66(1):32-48. doi: 10.1002/pros.20318.
引用本文的文献
1
Tumors hijack macrophages for iron supply to promote bone metastasis and anemia.
Cell. 2025 Aug 26. doi: 10.1016/j.cell.2025.08.013.
2
Antiresorptive agents in the management of bone metastatic disease: a multicenter mixed-methods study in Palestinian clinical practice.
BMC Cancer. 2025 Aug 27;25(1):1383. doi: 10.1186/s12885-025-14772-y.
3
Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?
JBMR Plus. 2025 Jun 20;9(9):ziaf108. doi: 10.1093/jbmrpl/ziaf108. eCollection 2025 Sep.
4
Stromal senescence contributes to age-related increases in cancer.
Nat Rev Cancer. 2025 Aug 4. doi: 10.1038/s41568-025-00840-9.
5
Exploring bone-tumor interactions through 3D models: Implications for primary and metastatic cancers.
J Bone Oncol. 2025 Jun 17;53:100698. doi: 10.1016/j.jbo.2025.100698. eCollection 2025 Aug.
6
Construction of a prostate adenocarcinoma molecular classification: integrating spatial transcriptomics with retrospective cohort validation.
J Transl Med. 2025 Jul 1;23(1):717. doi: 10.1186/s12967-025-06661-6.
7
miR-216 Is a Key Regulator and Potential Marker in Human Cancers.
Adv Biomed Res. 2025 May 31;14:40. doi: 10.4103/abr.abr_184_23. eCollection 2025.
8
The role of LGR4 in bone metabolism and tumor bone metastasis.
Front Endocrinol (Lausanne). 2025 May 21;16:1541601. doi: 10.3389/fendo.2025.1541601. eCollection 2025.
9
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization.
Cell Genom. 2025 Jul 9;5(7):100888. doi: 10.1016/j.xgen.2025.100888. Epub 2025 May 23.
10
Advances in spatial transcriptomics and its application in the musculoskeletal system.
Bone Res. 2025 May 16;13(1):54. doi: 10.1038/s41413-025-00429-w.
本文引用的文献
1
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.
J Clin Invest. 2011 Apr;121(4):1298-312. doi: 10.1172/JCI43414. Epub 2011 Mar 23.
2
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells.
Cancer Cell. 2011 Feb 15;19(2):192-205. doi: 10.1016/j.ccr.2010.12.022. Epub 2011 Feb 3.
3
Contribution of platelets to tumour metastasis.
Nat Rev Cancer. 2011 Feb;11(2):123-34. doi: 10.1038/nrc3004.
4
The amazing osteocyte.
J Bone Miner Res. 2011 Feb;26(2):229-38. doi: 10.1002/jbmr.320.
5
The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial.
Clin Breast Cancer. 2010 Dec 1;10(6):452-8. doi: 10.3816/CBC.2010.n.059.
6
PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis.
Cancer Res. 2011 Jan 1;71(1):164-74. doi: 10.1158/0008-5472.CAN-10-1708. Epub 2010 Nov 19.
7
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.
J Clin Oncol. 2010 Dec 10;28(35):5132-9. doi: 10.1200/JCO.2010.29.7101. Epub 2010 Nov 8.
8
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility.
Breast Cancer Res. 2010;12(5):R89. doi: 10.1186/bcr2762. Epub 2010 Oct 28.
9
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Nature. 2010 Nov 4;468(7320):103-7. doi: 10.1038/nature09495. Epub 2010 Sep 29.
10
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases.
Eur J Cancer. 2011 Jan;47(2):277-86. doi: 10.1016/j.ejca.2010.08.019. Epub 2010 Sep 20.
Zotero 插件